Asim Siddiqui's guest appearances

Asim Siddiqui

Mendelspod Podcast

Talking Precision Medicine

KalamCast

Hamza Tzortzis

Ismail Kamdar

Julie Walters

Adam Saad

Ethan Perlstein

Charlie Silver

Luba Greenwood

Zohra Sarwari

Mark Kiel

Gabe Musso

Yusuf Henriques

Olivier Elemento

Matthew Michelson

Elia Stupka

Annastasiah Mhaka

OwlTail

Margaret Donovan

It’s a thrilling time to be in proteomics.  Today we discuss a recent paper in PLOS One demonstrating how new technology has revealed a novel biomarker for non-small cell lung cancer previously undetected by other methods.  The paper could be a model for new proteomics research going forward.  Our guests are Margaret Donovan, Product Marketing Manager, and Asim Siddiqui, Senior VP of Research, both at proteomics company, Seer.

It’s a thrilling time to be in proteomics.  Today we discuss <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0282821" rel="nofollow" target="_blank">a recent paper in PLOS One</a> demonstrating how new technology has revealed a novel biomarker for non-small cell lung cancer previously undetected by other methods.  The paper could be a model for new proteomics research going forward.  Our guests are Margaret Donovan, Product Marketing Manager, and Asim Siddiqui, Senior VP of Research, both at proteomics company, Seer.

Proteomics Today Where Genomics Was in the 80s: Margaret Donovan and Asim Siddiqui of Seer on Landmark Study

Ahmad Jhaffar (a volunteer for over 2.5 years) and Asim Siddiqui (a volunteer for 7 years) stopped by to talk about their experiences as volunteer firefighters with Furqan and Mustapha. They discussed what it has been like for them so far, the type of commitment and training that is required for such a job, their interaction with other firefighters, their experiences with recent bushfire relief efforts, some of the general dangers involved in the work and how they link such volunteer activities to their Islamic belief. --- Send in a voice message: https://anchor.fm/kalamcast/message

Ahmad Jhaffar (a volunteer for over 2.5 years) and Asim Siddiqui (a volunteer for 7 years) stopped by to talk about their experiences as volunteer firefighters with Furqan and Mustapha. They discussed what it has been like for them so far, the type of commitment and training that is required for such a job, their interaction with other firefighters, their experiences with recent bushfire relief efforts, some of the general dangers involved in the work and how they link such volunteer activities to their Islamic belief. --- Send in a voice message: <a href="https://anchor.fm/kalamcast/message" rel="nofollow" target="_blank">https://anchor.fm/kalamcast/message</a>

EP 9: The Muslim Firefighters | Asim Siddiqui & Ahmad Jhaffar

In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling in precision medicine. We help accelerate the discovery and de-risk the development of novel therapeutics. From heterogeneous data and diverse information stores, we predict with confidence drug targets and biomarkers of tolerance, efficacy and outcome.In this episode we speak with Asim Siddiqui. Asim is the CTO at NuMedii—a data driven drug discovery company. He has deep experience in computational biology, software engineering, next-generation sequencing, and cancer informatics, and is responsible for architecting and applying NuMedii’s AIDD (Artificial Intelligence for Drug Discovery) technology. We talk about leveraging public data for discovery, communicating between data scientists, bench scientists and other stakeholders, and the potential and challenges of using AI to advance drug development.

In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling in precision medicine. We help accelerate the discovery and de-risk the development of novel therapeutics. From heterogeneous data and diverse information stores, we predict with confidence drug targets and biomarkers of tolerance, efficacy and outcome. In this episode we speak with Asim Siddiqui. Asim is the CTO at NuMedii—a data driven drug discovery company. He has deep experience in computational biology, software engineering, next-generation sequencing, and cancer informatics, and is responsible for architecting and applying NuMedii’s AIDD (Artificial Intelligence for Drug Discovery) technology. We talk about leveraging public data for discovery, communicating between data scientists, bench scientists and other stakeholders, and the potential and challenges of using AI to advance drug development.

AI, it’s all about the drugs with Asim Siddiqui | Talking Precision Medicine #01